[Advances on anti-tumor mechanisms of zerumbone]

Hong Yang1, Rong-Mei Dou1, Ting Yao1

  • 1School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100029, China.

Insights

Zerumbone (ZER), a sesquiterpenoid, exhibits potent anti-tumor properties by inhibiting cancer cell growth, promoting apoptosis, and enhancing immune function. This review summarizes ZER

Area of Science:

  • Natural Products Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Zerumbone (ZER) is a humulane-type sesquiterpenoid with demonstrated anti-cancer potential.
  • Understanding the molecular mechanisms of ZER is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To summarize the anti-tumor mechanisms of action of Zerumbone (ZER).
  • To provide a reference for future research on ZER's anti-cancer effects.

Main Methods:

  • Literature review of studies investigating Zerumbone's anti-tumor activities.
  • Analysis of documented mechanisms including cell proliferation inhibition, apoptosis induction, immune modulation, and metastasis prevention.

Main Results:

  • ZER inhibits cancer cell growth and proliferation.
  • ZER induces cancer cell apoptosis and differentiation.
  • ZER modulates immune function and inhibits cancer cell invasion and metastasis.
  • ZER has potential in reversing multidrug resistance in cancer cells.

Conclusions:

  • Zerumbone (ZER) possesses diverse anti-tumor mechanisms.
  • ZER represents a promising candidate for cancer treatment development.
  • Further research into ZER's mechanisms will aid in its therapeutic application.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K